3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Venous Thromboembolism
5
Neoplasms
2
Multiple Myeloma
2
Urologic Neoplasms
1
Urogenital Neoplasms
1
Pulmonary Embolism
1
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Embolism
1
Interventions
fludarabine
7
Cyclophosphamide
7
fludarabine phosphate
4
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Melphalan
2
Busulfan
2
Bendamustine Hydrochloride
2
AP 1903 reagent
2
pembrolizumab
1
ibrutinib
1
Surveys and Questionnaires
1
CA-4948
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immune System Diseases
×
Rivaroxaban
×
1 year
×
Clear all
No trials found.